期刊文献+

人血管内皮生长因子mRNA靶向siRNA表达载体的构建和表达 被引量:3

Vector construction and silencing effect of VEGF gene targeted small interfering RNA
下载PDF
导出
摘要 目的:构建人血管内皮生长因子(VEGF)mRNA靶向siRNA表达载体,观察其表达情况。方法:设计人VEGF靶向的发夹样siRNA,依据设计,合成2条互补的寡核苷酸链,退火后连接入pSUPERneo-GFP载体,转化扩增后得到重组载体pSUPERneo-GFP-siVEGF,进行序列测定。用脂质体转染法将重组载体转染食管癌细胞株Eca109,采用RT-PCR检测转染细胞VEGF mRNA的表达水平。结果:经过酶切鉴定与测序,pSUPERneo-GFP-siVEGF构建成功。稳定转染该重组体的Eca109细胞VEGF mRNA表达水平明显降低。结论:成功构建了针对VEGF mRNA的siRNA载体,转染细胞后可显著抑制VEGF mRNA的表达。 Aim: To construct VEGF gene-targeted small interfering RNA(siRNA) vector. Methods: VEGF gene-targeted hairpin siRNA was designed, then two complementary oligo nueleotide strand were synthesized and inserted into pSUPERneo-GFP vector after annealing to get the new vector pSUPERneo-GFP-siVEGF, which was digested by restrictive enzyme and sequenced. After that, the new vector was transfeeted into human esophageal carcinoma Eea109 cell using lipofeetamine method, and the mRNA exprssion level of VEGF gene in cells was detected by RT-PCR. Results and Conclusion: pSUPERneo-GFP-siVEGF is built successfully,and the expression level of VEGF mRNA in transfected Eca109 was decreased.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第2期231-233,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 教育部"十五"211工程重点学科建设项目教重办2002第2号
关键词 RNA干扰 VEGF 表达 RNA interference VEGF expression
  • 相关文献

参考文献3

二级参考文献31

  • 1吕伟,郝嘉,郝迎学,张超.RNAi抑制大肠癌HCT116细胞株VEGF-mRNA表达的实验研究[J].第三军医大学学报,2005,27(11):1089-1092. 被引量:6
  • 2Isobe T,Herbst RS,Onn A.Current management of advanced nonsmall cell lung cancer:targeted therapy[J].Semin Oncol,2005,32(3):315-28.
  • 3Mio T,Adachi Y,Romberger DJ,et al.Regulation of fibroblast proliferation in three dimensional collagen gel matrix[J].In vitro Cell Dev Biol,1996,32:427-33.
  • 4Midgley R,Kerr D.Bevacizumab-current status and future directions[J].Ann Oncol,2005,16(7):999-1004.
  • 5Singhal S,Vachani A,Antin-Ozerkis D,et al.Prognostic implications of cell cycle,apoptosis,and angiogenesis biomarkers in non-small cell lung cancer:a review[J].Clin Cancer Res.2005,11(11):3974-86.
  • 6Neri D,Bicknell R.Tumour vascular targeting[J].Nat Rev Cancer.2005,5(6):436-46.
  • 7Tozer GM,Kanthou C,Baguley BC.Disrupting tumour blood vessels[J].Nat Rev Cancer,2005,5.(6):423-35.
  • 8Fayette J,Soria JC,Armand JP.Use ofangiogenesis inhibitors in tumour treatment[J].Eur J Cancer,2005,41(8):1109-16.
  • 9FIRE A,XU S,MONTGOMERY M K,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [J].Nature,1998,391(6669):806 -811.
  • 10SCHERR M,MORGAN M A,EDER M.Gene silencing mediated by small interfering RNAs in mammalian cells [J].Curr Med Chem,2003,10(3):245 -256.

共引文献23

同被引文献37

  • 1Lusis A J. Atherosclerosis [ J ]. Nature, 2000, 407 (6801) : 233 - 241.
  • 2Sima A V, Stancu C S, Simionescu M. Vascular endothelium in atherosclerosis[J]. Cell Tissue Res, 2009, 335( 1 ) : 191 -203.
  • 3Vannini N, Pfeffer U, Lorusso G. Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model [J]. Curr Pharm Des, 2008, 14(3) : 221 -225.
  • 4Holvoet P, Jenny N S, Schreiner P J, et al. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: lhe Multi-Ethnic Study of Athcroselerosis (MESA) [J]. Atherosclerosis, 2007, 194( 1 ) : 245 -252.
  • 5Puddu G M, Cravero E, Arnone G, et al. Molecular aspects of atherogenesis: new insights and unsolved questions [ J ]. J Biomed Sci, 2005, 12(6): 839-853.
  • 6Affara M, Dunmore B, Savoie C, et al. Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal? [ J]. Philos Trans R Soc Lond B Biol Sci, 2007, 362(1484) : 1469 - 1487.
  • 7Choy J C, Granville D J, Hunt D W, et al. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis [J]. J Mol Cell Cardiol, 2001, 33(9) : 1673 -1690.
  • 8Skowasch D, Jabs A, Andrie R, et al. Pathogen burden, inflanunation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis [ J]. J Vasc Res, 2004, 41 (6) : 525 -534.
  • 9Yang M H, Yoo K H, Yook Y J , et al. The gene expression profiling in murine cortical cells undergoing programmed cell death (PCD) induced by serum deprivation [ J ]. J Biochem Mol Biol, 2007, 40 (2) : 277 - 285.
  • 10McConkey D J, Nicotera P, Orrenius S. Signalling and chromatin fragmentation in thymocyte apoptosis[J]. Immunol Rev, 1994, 142: 343 - 363.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部